Loading...
Loading...
India's serum imports from CHINA total $1.2M across 90 shipments from 15 foreign suppliers. HANGZHOU BIOTEST BIOTECH CO.LTD. leads with $210.9K in import value; the top 5 suppliers together control 70.0% of this origin. Leading Indian buyers include AGAPPE DIAGNOSTICS LIMITED. This corridor reflects India's pharmaceutical import demand for serum โ a diversified sourcing base with multiple active suppliers from CHINA.

HANGZHOU BIOTEST BIOTECH CO.LTD. is the leading Serum supplier from CHINA to India, with import value of $210.9K across 6 shipments. The top 5 suppliers โ HANGZHOU BIOTEST BIOTECH CO.LTD., HANGZHOU BIOTEST BIOTECH CO., LTD, WUXI APPTEC (SUZHOU) CO.LTD., HUBEI NEW DESHENG MATERIALS TECHNOL, HANGZHOU BIOTEST BIOTECH CO LIMITED โ collectively account for 70.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | HANGZHOU BIOTEST BIOTECH CO.LTD. | $210.9K | 6 | 17.7% |
| 2 | HANGZHOU BIOTEST BIOTECH CO., LTD | $210.1K | 5 | 17.6% |
| 3 | WUXI APPTEC (SUZHOU) CO.LTD. | $183.5K | 8 | 15.4% |
| 4 | HUBEI NEW DESHENG MATERIALS TECHNOL | $119.3K | 7 | 10.0% |
| 5 | HANGZHOU BIOTEST BIOTECH CO LIMITED | $110.8K | 2 | 9.3% |
| 6 | HUBEI NEW DESHENG MATERIALS TECHNOLOGY CO LIMITED | $109.9K | 2 | 9.2% |
| 7 | HANGZHOU BIOTEST BIOTECH CO LTD | $93.2K | 3 | 7.8% |
| 8 | SPAN BIOTECH LIMITED | $48.2K | 2 | 4.0% |
| 9 | HUBEI NEW DESHENG MATERIALS TECHNOLOGY CO.,LTD. | $31.9K | 6 | 2.7% |
| 10 | SHANGHAI JELL BIOLOGICAL TECHNOLOGY | $18.8K | 2 | 1.6% |
| 11 | SHANGHAI JELL BIOLOGICAL TECHNOLOGY CO LTD | $16.8K | 1 | 1.4% |
| 12 | SHANGHAI JELL BIOLOGICAL TECHNOLOGY CO., LTD | $16.8K | 3 | 1.4% |
| 13 | HANGZHOU BIOTEST BIOTECH CO., LTD. | $7.6K | 3 | 0.6% |
| 14 | HANGZHOU ALLTEST BIOTECH CO LIMITED | $4.7K | 2 | 0.4% |
| 15 | XIAN TAICHENG CHEM CO., LTD. | $4.2K | 2 | 0.4% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AGAPPE DIAGNOSTICS LIMITED | $622.2K | 15 | 52.2% |
| 2 | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED | $183.5K | 9 | 15.4% |
| 3 | A V CONSUMABLES | $141.8K | 8 | 11.9% |
| 4 | KRUPA LABEQUI | $119.3K | 7 | 10.0% |
| 5 | NASMED DIAGNOSTIC PRIVATE LIMITED | $53.3K | 7 | 4.5% |
| 6 | RECKON DIAGNOSTICS PRIVATE LIMITED | $24.2K | 1 | 2.0% |
| 7 | RECKON DIAGNOSTICS PVT. LTD. | $23.9K | 1 | 2.0% |
| 8 | BHAT BIO-TECH INDIA PRIVATE LIMITED | $7.6K | 3 | 0.6% |
| 9 | BIOTROL LABORATORIES PRIVATE LIMITED | $4.7K | 2 | 0.4% |
| 10 | SHETH TRADING COMPANY | $4.2K | 2 | 0.4% |
| 11 | BHAT BIOTECH INDIA P LTD | $2.8K | 1 | 0.2% |
| 12 | HIMEDIA LABORATORIES PRIVATE LIMITED | $1.9K | 1 | 0.2% |
| 13 | YUCCA DIAGNOSTICS | $1.2K | 1 | 0.1% |
| 14 | KRISHGEN BIOSYSTEMS | $864 | 5 | 0.1% |
| 15 | AMPLICON BIOTECH | $415 | 2 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Serum suppliers from CHINA to India include HANGZHOU BIOTEST BIOTECH CO.LTD., HANGZHOU BIOTEST BIOTECH CO., LTD, WUXI APPTEC (SUZHOU) CO.LTD.. The leading supplier is HANGZHOU BIOTEST BIOTECH CO.LTD. with import value of $210.9K USD across 6 shipments. India imported Serum worth $1.2M USD from CHINA in total across 90 shipments.
India imported Serum worth $1.2M USD from CHINA across 90 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Serum sourced from CHINA include AGAPPE DIAGNOSTICS LIMITED, SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED, A V CONSUMABLES. The largest buyer is AGAPPE DIAGNOSTICS LIMITED with $622.2K in imports across 15 shipments.
The total value of Serum imports from CHINA to India is $1.2M USD, across 90 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
90 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists